A U.S. congressional hearing exposed inflammatory text messages sent by a Border Patrol agent involved in the shooting of an American citizen in Chicago, as families of other victims testified about lethal encounters with immigration enforcement officers.
Swiss pharmaceutical giant Novartis forecasts a low single-digit percentage decline in its 2026 operating profit, citing intensifying pressure from generic rivals to key drugs like Entresto.
SoFi Technologies is aggressively expanding its cryptocurrency offerings, launching secured crypto-backed loans and institutional trading services. This strategic pivot, coupled with robust member growth, signals a broader ambition to compete in the digital asset arena, reshaping its investment narrative beyond traditional banking.
As Iran grapples with economic turmoil, state-imposed internet restrictions are costing the economy an estimated $37.4 million per day, while VPN demand surges nearly 600% as citizens seek digital lifelines.
Amidst the frenzy for AI and tech stocks, Hamilton Insurance Group presents a compelling case as a fundamentally strong, cash-generative business trading at a deep value. With premiums and free cash flow soaring, analysts question if the market has yet to price in its robust growth.
As the artificial intelligence revolution drives an unprecedented surge in electricity demand, advanced nuclear energy developer Oklo Inc. is emerging as a critical infrastructure player. Analysts highlight its unique positioning to provide clean, reliable power for data centers, with significant growth potential on the horizon.
As Teva Pharmaceutical shifts focus from its legacy generics business to a promising innovative pipeline, its experimental drug Duvakitug emerges as a potential valuation catalyst. We examine the bull case, the competitive landscape, and what it means for investors.
Recent analyst reports from Wells Fargo and H.C. Wainwright suggest consensus revenue estimates for biotech firm Argenx SE may be too conservative, with key drug Vyvgart poised to outperform expectations through 2030.
Volkswagen's Scout Motors has seen the budget for its South Carolina electric vehicle factory balloon by $1 billion to $3 billion, citing facility expansion and supply chain investments as key drivers, even as the U.S. EV market cools.
A House hearing exposed disturbing text messages in which a Customs and Border Protection agent boasted about shooting a Chicago woman, fueling scrutiny of federal immigration enforcement tactics.
South Carolina Republican Nancy Mace has forcefully denied a magazine profile's claims that she ordered staff to deliver liquor after midnight, revealing a lifelong genetic condition that she says makes alcohol consumption dangerous. The allegations, countered by sharp criticism from a former aide, emerge as Mace faces a separate ethics committee probe.
Amidst the blockbuster success of its weight-loss drugs, pharmaceutical giant Eli Lilly is making a strategic push into genetic medicine, securing exclusive rights to novel hearing loss treatments through a major partnership with German biotech Seamless Therapeutics.
Take-Two Interactive Software's fair value estimate sees a modest upward revision, driven by adjusted discount rates and slightly improved growth projections. Analysts are factoring in potential efficiency gains from generative AI and strong engagement signals from recent Grand Theft Auto Online updates.
Analysts have raised Genco Shipping & Trading's fair value estimate to $24.10 per share, signaling a belief that the dry bulk carrier's prospects extend beyond Diana Shipping's cash offer of $20.60 per share. The revision reflects adjusted assumptions on discount rates and revenue growth, setting the stage for a potential bidding war or strategic review.
Dollar General (DG) is witnessing a significant resurgence, driven by stronger-than-expected fourth-quarter performance marked by robust same-store sales and expanding margins. Investor optimism is reflected in a dramatic 90-day share price surge, though long-term returns tell a more complex story.
Despite a steady rise in earnings per share, Genting Plantations Berhad (KLSE:GENP) has seen its share price plummet 46% over the past five years, leaving long-term shareholders questioning their holdings. We delve into the disconnect between performance and market sentiment.
Amgen reported robust 2025 results, driven by double-digit growth across its portfolio, and provided a confident outlook for 2026. While highlighting key growth drivers like Repatha and MariTide, the company also addressed portfolio pruning and an ongoing regulatory dialogue concerning Tavneos.
After a transformative 2025, SoundHound AI is leveraging its voice-first technology and the acquisition of Amelia to challenge for leadership in the burgeoning agentic AI market, with profitability on the horizon.
A sharp sell-off in major video game stocks followed Google's unveiling of its 'Project Genie' AI. An industry analyst argues the market has misunderstood both the technology's capabilities and the fundamental nature of game development.
Brothers of Renee Good, a mother of three fatally shot by an ICE agent in Minneapolis, told a congressional hearing that her death has not led to promised changes in enforcement tactics, expressing grief and frustration over a lack of accountability.
